International Journal of Clinical Research

Objective To analyze the anesthetic efficacy and impact on recovery time of remimazolam besylate and propofol in hysteroscopic surgery. Methods A total of 90 patients who underwent hysteroscopic surgery in our hospital from January 15, 2021 to January 15, 2024 were enrolled as research subjects. They were divided into the new group (45 cases) and the traditional group (45 cases) according to the order of medical consultation. The traditional group was anesthetized with propofol, while the new group was anesthetized with remimazolam besylate. The results were analyzed. Results Before surgery, there were no significant differences in DBP, SBP, HR and SPO₂ between the two groups (P > 0.05). During and after surgery, the above indicators in the new group showed no significant changes compared with those before surgery (P > 0.05), while those in the traditional group fluctuated significantly (P < 0.05). Compared with the traditional group, the new group had significantly shorter recovery time, orientation recovery time and anesthesia onset time (P < 0.05). The postoperative VAS score in the new group was lower than that in the traditional group (P < 0.05). The incidence of adverse reactions was 37.78% in the traditional group and 4.44% in the new group. The new group had a significantly lower incidence of surgical adverse reactions than the traditional group (P < 0.05). Conclusion For patients undergoing hysteroscopic surgery, remimazolam besylate has better anesthetic efficacy than propofol. This method is worthy of further promotion and application.

Remimazolam besylate; Propofol; Hysteroscopic surgery; Anesthetic efficacy; Recovery time; Impact analysis